News Archives

This is the archive of news updates from the Fuji Pharma website.
Click on each news item to view the full details.

2025.11.04
Release(リリース): Notice of Settlement and License Agreement Regarding Golimumab BS (Biosimilar)
2025.10.31
Release(リリース): Notice of Agreement Regarding Denosumab BS (Biosimilar)
2025.10.01
Release(リリース): Notice of Application for Additional Approval of indication of NextstellisTM by OLIC (Thailand) Limited
2025.09.19
Release(リリース): Marketing Approval for Three Biosimilars Aflibercept, Golimumab, Denosumab
2025.08.22
Other(その他): Corporate Report 2025 (English version) has been published
2025.08.07
Financial Results(決算資料): Supplemental Materials of 3Q/FY2025 Consolidated Financial Results
2025.08.07
Financial Results(決算資料): Financial Results of 3Q/FY2025
2025.08.01
Release(リリース): Notice Concerning Completion Acquisition and Cancellation of the 1st Series of Stock Acquisition Rights with Exercise Price Revision Clause
2025.07.25
Product(製品情報): Initiation of Phase Ⅲ clinical trial for the Alyssa® combination tablets
2025.07.17
Release(リリース): Notice Concerning Acquisition and Cancellation of the 1st Series of Stock Acquisition Rights with Exercise Price Revision Clause